When asked about the significance of this contract, Ms. Jennifer Marcum, Sentry's CEO, stated that "earning a GSA Contract is not only a testament to Sentry BioPharma's expertise as a biopharmaceutical warehousing and logistics provider and its ability to expeditiously implement key projects.
It is also a validation of our international services, as the application process includes an extensive review of Sentry's prior experience with temperature-controlled vaccine and pharmaceutical storage and logistics, as well as a survey of our clients' satisfaction with our company." Marcum further elaborated by stating that "Sentry's biopharmaceutical storage and drug distribution services are perfectly designed and constructed to support any government agency's needs for the cGMP storage, labeling, kitting and distribution of temperature-sensitive pharmaceutical products, including vaccines and regulated medications." Finally, Marcum stressed that "by investing the resources to complete the GSA contracting process, Sentry expects to gain efficiencies when contracting with federal agencies like Department of Defense (DOD), the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs (VA)." Additional information regarding Sentry's GSA Contract can be found at GSA eLibrary.